Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul 24;17(15):2419.
doi: 10.3390/nu17152419.

Potential Health Benefits of Dietary Tree Nut and Peanut Enrichment in Kidney Transplant Recipients-An In-Depth Narrative Review and Considerations for Future Research

Affiliations
Review

Potential Health Benefits of Dietary Tree Nut and Peanut Enrichment in Kidney Transplant Recipients-An In-Depth Narrative Review and Considerations for Future Research

Daan Kremer et al. Nutrients. .

Abstract

Kidney transplant recipients face a substantial burden of premature mortality and morbidity, primarily due to persistent inflammation, cardiovascular risk, and nutritional deficiencies. Traditional nutritional interventions in this population have either focused on supplementing individual nutrients-often with limited efficacy-or required comprehensive dietary overhauls that compromise patient adherence. In this narrative review, we explore the rationale for dietary nut enrichment as a feasible, multi-nutrient strategy tailored to the needs of kidney transplant recipients. Nuts, including peanuts and tree nuts with no added salt, sugar, or oil, are rich in beneficial fats, proteins, vitamins, minerals, and bioactive compounds. We summarize the multiple post-transplant challenges-including obesity, sarcopenia, dyslipidemia, hypertension, immunological dysfunction, and chronic inflammation-and discuss how nut consumption may mitigate these issues through mechanisms involving improved micro-nutrient intake (e.g., magnesium, potassium, selenium), lipid profile modulation, endothelial function, immune support, and gut microbiota health. Additionally, we highlight the scarcity of randomized controlled trials in high-risk populations such as kidney transplant recipients and make the case for studying this group as a model for investigating the clinical efficacy of nuts as a nutritional intervention. We also consider practical aspects for future clinical trials, including the choice of study population, intervention design, duration, nut type, dosage, and primary outcome measures such as systemic inflammation. Finally, potential risks such as nut allergies and oxalate or mycotoxin exposure are addressed. Altogether, this review proposes dietary nut enrichment as a promising, simple, and sustainable multi-nutrient approach to support cardiometabolic and immune health in kidney transplant recipients, warranting formal investigation in clinical trials.

Keywords: aging; dietary intervention; fibrosis; inflammation; kidney transplant recipients; micro-nutrients; nuts; oxidative stress; very long-chain saturated fatty acids.

PubMed Disclaimer

Conflict of interest statement

Intersnack Nederland B.V. (Doetinchem, The Netherlands) is a nut supplier that will provide the necessary nut supply for conducting the planned intervention study. This project is further supported by means of a PPP-allowance, made available by the Top Sector Life Sciences & Health to stimulate public–private partnerships (project code: PPP2023-006). All financial support for this project was transferred to non-private/institutional accounts. The funders had no role in the study design, data collection, analysis, reporting, or the decision to submit for publication. The authors declare no other relevant conflicts of interest.

Figures

Figure 1
Figure 1
Overview of selected nutrients present in nuts that have suggested beneficial effects on cardiovascular risk, inflammation and the immune system in kidney transplant recipients. Abbreviations: B, boron; K, potassium; Mg, magnesium; Se, selenium; Zn, zinc.
Figure 2
Figure 2
Flow diagram of a parallel randomized controlled trial of mixed nut intervention in kidney transplant recipients.

Similar articles

References

    1. Hariharan S., Israni A.K., Danovitch G. Long-Term Survival after Kidney Transplantation. N. Engl. J. Med. 2021;385:729–743. doi: 10.1056/NEJMra2014530. - DOI - PubMed
    1. Ying T., Shi B., Kelly P.J., Pilmore H., Clayton P.A., Chadban S.J. Death after Kidney Transplantation: An Analysis by Era and Time Post-Transplant. J. Am. Soc. Nephrol. 2020;31:2887–2899. doi: 10.1681/ASN.2020050566. - DOI - PMC - PubMed
    1. Sotomayor C.G., te Velde-Keyzer C.A., de Borst M.H., Navis G.J., Bakker S.J.L. Lifestyle, Inflammation, and Vascular Calcification in Kidney Transplant Recipients: Perspectives on Long-Term Outcomes. J. Clin. Med. 2020;9:1911. doi: 10.3390/jcm9061911. - DOI - PMC - PubMed
    1. Kremer D., Alkaff F.F., Post A., Knobbe T.J., Tepel M., Thaunat O., Berger S.P., van den Born J., Genovese F., Karsdal M.A., et al. Plasma endotrophin, reflecting tissue fibrosis, is associated with graft failure and mortality in KTRs: Results from two prospective cohort studies. Nephrol. Dial. Transplant. 2022;38:gfac332. doi: 10.1093/ndt/gfac332. - DOI - PMC - PubMed
    1. Abedini S., Holme I., März W., Weihrauch G., Fellström B., Jardine A., Cole E., Maes B., Neumayer H.H., Grønhagen-Riska C., et al. Inflammation in Renal Transplantation. Clin. J. Am. Soc. Nephrol. 2009;4:1246–1254. doi: 10.2215/CJN.00930209. - DOI - PMC - PubMed

LinkOut - more resources